Close Menu
Beverly Hills Examiner

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Startup sues Apple in India over tap-to-share contacts feature | TechCrunch

    November 21, 2026

    The US to become first nation to fully shun a UN Human Rights Council review

    November 21, 2026

    Grimes Releases Two New Psy Opera Songs

    November 20, 2026
    Facebook X (Twitter) Instagram
    Beverly Hills Examiner
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    Beverly Hills Examiner
    Home»Science»Technology Is Reshaping Sleep Apnea Treatment
    Science

    Technology Is Reshaping Sleep Apnea Treatment

    By AdminMarch 11, 2026
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Technology Is Reshaping Sleep Apnea Treatment

    [ad_1]

    Inspire therapy—a hypoglossal nerve stimulation implant—has been FDA-approved for more than 11 years, with over 100,000 patients treated across the US, Europe, and Asia. Ruchir Patel, Inspire’s senior medical director, says data show reductions in daytime sleepiness, a 79 percent drop in sleep apnea severity, and a 90 percent reduction in snoring. Early US data report average nightly usage of more than 6.5 hours. “This is an exciting time because there are more treatment options available than in the past,” he says.

    Pharmaceutical approaches are also emerging. In 2024, the US Food and Drug Administration approved Zepbound (tirzepatide) for moderate to severe OSA in adults with obesity—the first weight-loss drug to carry a specific sleep apnea indication.

    Meanwhile, Cambridge, Massachusetts–based startup Apnimed has developed a nightly pill targeting neuromuscular pathways that influence upper airway tone. Rather than mechanically splinting the airway open, the drug aims to stabilize it biologically.

    “For a long time, OSA was understood primarily as an anatomical problem, so the logical solution was mechanical,” says John Cronin, chief medical officer at Apnimed. As understanding evolved, the question became: “Could we design a therapy that targets the biology of the condition directly, rather than relying solely on mechanical support?” The company has completed two phase three trials and plans to submit a New Drug Application to the FDA this year.

    For all the innovation, Steier remains pragmatic. “I couldn’t be happier than finding someone who’s got typical sleep apnea and gets CPAP therapy,” he says. Modern machines automatically adjust pressure to airway resistance. “A single night can make all the difference.” Patients return re-energized, telling him they’ve got their lives back.

    Sleep medicine is still relatively young, and research is only beginning to capture the diversity of the condition. That complexity also underpins efforts to improve CPAP use rather than abandon it.

    Amanda Sathyapala, an associate professor at Imperial College London’s National Heart and Lung Institute, led the research showing 62 percent of patients were not using CPAP enough to make a meaningful health impact. Her team has studied the psychology of adherence, finding that factors such as understanding risk and confidence using the device shape long-term use.

    Drawing on behavioral science, she developed CPAP Buddy, an app offering video-based behavioral therapy, peer support, and round-the-clock answers to patient questions. The project has received £2.2 million from the UK’s Medical Research Council, alongside backing from CPAP manufacturer Fisher & Paykel.

    “CPAP is likely to be the most effective treatment that you can get because it’s giving air directly into the airway,” Sathyapala says. “[CPAP] is always going to be the most efficacious once the person’s using it, therefore it’s worth trying to get people to use it.”

    For her, the problem is not the machine but behavior. “I don’t like to give up if we haven’t tried the right things,” she says. Using CPAP, she adds, is no different from “losing weight, stopping smoking, starting up a long-term physical activity program—it’s a behavior change.”

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleHong Kong Film Festival to Open With Anthony Chen’s ‘We Are All Strangers,’ Close With Philip Yung’s ‘Cyclone’
    Next Article Anduril snaps up space surveillance firm ExoAnalytic Solutions

    RELATED POSTS

    Voyager 1 Beat the Odds and Is Still Working a Light-Day Away From Earth

    November 18, 2026

    The Dark Side of the Moon Was the Brightest Part of 2026

    November 17, 2026

    Just 400 US Data Centers Use More Electricity Than Michigan

    November 16, 2026

    The EPAs Chemical-Detecting Plane Isnt Doing Its Job Anymore

    November 16, 2026

    Its Getting Too Dry for Even Cactuses to Survive

    November 15, 2026

    New Species of Giant Fungus Discovered in China Grows up to 20 Inches Tall

    November 15, 2026
    latest posts

    Startup sues Apple in India over tap-to-share contacts feature | TechCrunch

    Apple is being sued in India by a U.S.-based startup that alleges the iPhone maker’s…

    The US to become first nation to fully shun a UN Human Rights Council review

    November 21, 2026

    Grimes Releases Two New Psy Opera Songs

    November 20, 2026

    Book Riots Deals of the Day for November 20, 2026

    November 20, 2026

    Chips can survive the space environment. Can their financing? | TechCrunch

    November 20, 2026

    AI stocks are selling off after Anthropics record IPO, and Wall Street is split on whether this is the top | Fortune

    November 20, 2026

    NYC sightseeing helicopter makes emergency landing after reporting possible engine trouble

    November 20, 2026
    Categories
    • Books (1,620)
    • Business (6,525)
    • Cover Story (17)
    • Film (6,459)
    • Lifestyle (4,500)
    • Music (6,535)
    • Politics (6,510)
    • Science (5,865)
    • Technology (6,463)
    • Television (6,156)
    • Uncategorized (3)
    • US News (6,509)
    popular posts

    Canadian Auto Workers Reach Deal With Stellantis After Brief Strike

    [ad_1] Updated Oct. 30, 2023 9:20 am ETTORONTO—Canadian auto workers reached a tentative deal with…

    2023 Was the Hottest Year on Record by a Long Shot

    January 15, 2024

    Exclusive: Accounting AI startup Rillet reaches unicorn status with $1 billion valuation. Its founder says he wants to give CFOs back their weekends

    August 19, 2026

    Moon Pod sale: Take 25% off sitewide

    June 20, 2022
    Archives
    Browse By Category
    • Books (1,620)
    • Business (6,525)
    • Cover Story (17)
    • Film (6,459)
    • Lifestyle (4,500)
    • Music (6,535)
    • Politics (6,510)
    • Science (5,865)
    • Technology (6,463)
    • Television (6,156)
    • Uncategorized (3)
    • US News (6,509)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    AI stocks are selling off after Anthropics record IPO, and Wall Street is split on whether this is the top | Fortune

    November 20, 2026

    NYC sightseeing helicopter makes emergency landing after reporting possible engine trouble

    November 20, 2026

    Billie Eilish to Headline BST Hyde Park for First Time: She Inspires Fans, Challenges Our Industry to Be Better

    November 20, 2026
    © 2026 Beverly Hills Examiner. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT